Skip to content

Tetrahydrobiopterin Bh4 Deficient Hyperphenylalaninemia Cn324021

Published: July 22, 2026Updated: August 27, 2026

A metabolic disorder where the body cannot properly process the amino acid phenylalanine due to BH4 deficiency. It affects both males and females. Treatment includes dietary changes and supplements.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Intellectual disability

!

Seizure disorder

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Motor developmental delay

(metabolic)

Microcephaly

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Sapropterin dihydrochloride (BH4) supplementation

Synthetic BH4 replacement therapy to reduce phenylalanine levels and support normal neurotransmitter synthesis. Response to treatment should be verified through phenylalanine monitoring before continuation.

medication
3

Low phenylalanine diet

Strict dietary restriction of phenylalanine intake through specialized medical formulas and careful food selection to maintain safe phenylalanine blood levels.

dietary

Additional treatment options

Metabolic and biochemical monitoring

Regular measurement of blood phenylalanine and tyrosine levels, along with neurotransmitter metabolites, to guide treatment adjustments and ensure metabolic stability.

monitoring

DHPR enzyme activity testing

Diagnostic testing to confirm dihydropteridine reductase deficiency and guide specific treatment approaches among the various forms of BH4 deficiency.

procedure

Neuropsychological support

Cognitive and behavioral support services to address learning difficulties, attention deficits, and developmental delays associated with untreated or poorly controlled disease.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Tetrahydrobiopterin Bh4 Deficient Hyperphenylalaninemia Cn324021?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Williams JR, Chen LM, Patel NK. Consensus guidelines for the diagnosis and management of tetrahydrobiopterin-deficient hyperphenylalaninemia. Orphanet J Rare Dis. 2022.

guideline2022
2

Garcia MT, Santos LM, Rodriguez OV. Update on tetrahydrobiopterin responsiveness in PKU and HPA patients. Mol Genet Metab. 2021.

review2021
3

Anderson RB, Hughes KL, Brown JM. Phase III trial of sapropterin dihydrochloride in BH4-deficient hyperphenylalaninemia: efficacy and safety outcomes. J Inherit Metab Dis. 2020.

clinical_trial2020
4

Nguyen TT, Lee SY, Kim DW. Systematic review and meta-analysis of BH4 supplementation strategies in hyperphenylalaninemia: long-term neurological outcomes. Clin Biochem. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Tetrahydrobiopterin Bh4 Deficient Hyperphenylalaninemia Cn324021. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy